Abstract
Sera collected in 1950 from the native population in the vicinity of Cairo, Egypt, have been tested for complement-fixing antibodies to Type 2 (Lansing) poliomyelitis virus. Complement-fixing antibodies are confined to the age of 1 to 9 years if a serum dilution of 1:4 is used in the test, or to the age of 1 to 4 years with a serum dilution of 1:16. A comparison has been made of the findings obtained in this study with the results for neutralizing antibodies previously reported. Complement-fixing antibodies were found to be temporary in nature while neutralizing antibodies were maintained for long periods of time. On this basis, criteria for "recent," "old," or "no infection" in poliomyelitis have been established. Sixteen of the children were bled again in 1952, 18 months after the first bleeding and both series of sera were compared in complement fixation and neutralization tests. All children who were negative in 1950 and who developed c-f antibodies by 1952, also developed neutralizing antibodies to a titer of more than 1:250 during the same period. Some children who failed to develop c-f antibodies, did develop neutralizing antibodies although of lower titer than found in children in whom c-f antibodies made their appearance. These findings are discussed in the light of theories regarding the mode of acquisition of antibodies to poliomyelitis virus.
Full Text
The Full Text of this article is available as a PDF (520.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CASALS J. Acetone-ether extracted antigens for complement-fixation with certain neurotropic viruses. Proc Soc Exp Biol Med. 1949 Feb;70(2):339–343. doi: 10.3181/00379727-70-16921. [DOI] [PubMed] [Google Scholar]
- CASALS J., OLITSKY P. K., ANSLOW R. O. A specific complement-fixation test for infection with poliomyelitis virus. J Exp Med. 1951 Aug;94(2):123–137. doi: 10.1084/jem.94.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CASALS J., OLITSKY P. K., ANSLOW R. O. Adaptation of a Lansing strain of poliomyelitis virus to newborn mice. J Exp Med. 1951 Aug;94(2):111–121. doi: 10.1084/jem.94.2.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LAHELLE O. Complement-fixation test for the Lansing strain of poliomyelitis virus. Am J Hyg. 1951 Nov;54(3):391–401. doi: 10.1093/oxfordjournals.aje.a119494. [DOI] [PubMed] [Google Scholar]
- MELNICK J. L., LEDINKO N. Social serology; antibody levels in a normal young population during an epidemic of poliomyelitis. Am J Hyg. 1951 Nov;54(3):354–382. doi: 10.1093/oxfordjournals.aje.a119492. [DOI] [PubMed] [Google Scholar]
- PAUL J. R., MELNICK J. L., BARNETT V. H., GOLDBLUM N. A survey of neutralizing antibodies to poliomyelitis virus in Cairo, Egypt. Am J Hyg. 1952 May;55(3):402–413. doi: 10.1093/oxfordjournals.aje.a119532. [DOI] [PubMed] [Google Scholar]
- PAUL J. R., RIORDAN J. R. Observations on serological epidemiology antibodies to the Lansing strain of poliomyelitis virus in sera from Alaskan eskimos. Am J Hyg. 1950 Sep;52(2):202–212. [PubMed] [Google Scholar]
- Paul J. R., Havens W. P., Van Rooyen C. E. Poliomyelitis in British and American Troops in the Middle East. Br Med J. 1944 Jun 24;1(4355):841–843. doi: 10.1136/bmj.1.4355.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SVEDMYR A., ENDERS J. F., HOLLOWAY A. Complement fixation with Brunhilde and Lansing poliomyelitis viruses propagated in tissue culture. Proc Soc Exp Biol Med. 1952 Feb;79(2):296–300. doi: 10.3181/00379727-79-19357. [DOI] [PubMed] [Google Scholar]
- TURNER T. B., HOLLANDER D. H., BUCKLEY S., KOKKO U. P., WINSOR C. P. Age incidence and seasonal development of neutralizing antibodies to lansing poliomyelitis virus. Am J Hyg. 1950 Nov;52(3):323–347. doi: 10.1093/oxfordjournals.aje.a119427. [DOI] [PubMed] [Google Scholar]